Argitalpenak (92) PATRICIA ASPICHUETA CELAA argitalpenak

2024

  1. Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)

    Hepatology, Vol. 79, Núm. 1, pp. 135-148

  2. The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis

    Journal of Gastroenterology

  3. Thyroid hormone receptor alpha modulates fibrogenesis in hepatic stellate cells

    Liver International, Vol. 44, Núm. 1, pp. 125-138

2023

  1. Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS−/− mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

    NMR in Biomedicine, Vol. 36, Núm. 8

  2. Expanding the roles of the renin–angiotensin system: Drug-induced liver injury

    Journal of Hepatology

  3. Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting

    Cell Metabolism, Vol. 35, Núm. 8, pp. 1373-1389.e8

  4. In Vivo Hepatic Triglyceride Secretion Rate in Antisense Oligonucleotide (ASO)-Treated Mice

    Methods in molecular biology (Clifton, N.J.), Vol. 2675, pp. 15-26

  5. In Vivo Tissue Lipid Uptake in Antisense Oligonucleotide (ASO)-Treated Mice

    Methods in molecular biology (Clifton, N.J.), Vol. 2675, pp. 1-13

  6. Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLD

    Metabolism: Clinical and Experimental, Vol. 145

  7. miR-21p-5p coordinates biological pathways to promote MASLD progression

    Liver International

2022

  1. Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids

    Hepatology, Vol. 76, Núm. 6, pp. 1617-1633

  2. Genetics, pathobiology and therapeutic opportunities of polycystic liver disease

    Nature Reviews Gastroenterology and Hepatology, Vol. 19, Núm. 9, pp. 585-604

  3. Global multi-stakeholder endorsement of the MAFLD definition

    The Lancet Gastroenterology and Hepatology

  4. Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function

    Journal of Hepatology, Vol. 76, Núm. 1, pp. 11-24

  5. Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis

    Nature Communications, Vol. 13, Núm. 1

  6. Role of Oxidative Stress and Lipid Peroxidation in the Pathophysiology of NAFLD

    Antioxidants, Vol. 11, Núm. 11

  7. TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation

    Journal of Hepatology, Vol. 77, Núm. 4, pp. 991-1004

  8. Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity

    Cancers, Vol. 14, Núm. 19

  9. Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models

    Journal of Hepatology, Vol. 77, Núm. 1, pp. 177-190

2021

  1. A uhplc-mass spectrometry view of human melanocytic cells uncovers potential lipid biomarkers of melanoma

    International Journal of Molecular Sciences, Vol. 22, Núm. 21